Glimepiride 3 mg

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 72336-641
  • Package NDC 72336-641-01
  • Application number ANDA091220
  • SPL ID 8f56950f-d08d-44d4-9c7c-9830e9bfadb8
  • SPL set ID 51157849-7990-4a8b-ae50-eda1baf93cfa
  • UNII 6KY687524K
  • RxCUI 153842

What the source publishes

Labeler
Lifsa Drugs LLC
Active ingredients
Glimepiride
Form
TABLET
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:72336-641_8f56950f-d08d-44d4-9c7c-9830e9bfadb8
{
  "name": "Glimepiride 3 mg",
  "splId": "8f56950f-d08d-44d4-9c7c-9830e9bfadb8",
  "labels": [
    {
      "setId": "51157849-7990-4a8b-ae50-eda1baf93cfa",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=51157849-7990-4a8b-ae50-eda1baf93cfa",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=51157849-7990-4a8b-ae50-eda1baf93cfa"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Lifsa Drugs LLC",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "100 TABLET in 1 BOTTLE (72336-641-01)",
      "package_ndc": "72336-641-01",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20240820"
    }
  ],
  "productId": "72336-641_8f56950f-d08d-44d4-9c7c-9830e9bfadb8",
  "useDomain": "unknown",
  "dosageForm": "TABLET",
  "productNdc": "72336-641",
  "deaSchedule": null,
  "genericName": "Glimepiride",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "GLIMEPIRIDE",
      "strength": "3 mg/1"
    }
  ],
  "applicationNumber": "ANDA091220",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20240820",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175608",
      "M0020795"
    ],
    "upc": [
      "0372336641012"
    ],
    "unii": [
      "6KY687524K"
    ],
    "rxcui": [
      "153842"
    ],
    "spl_set_id": [
      "51157849-7990-4a8b-ae50-eda1baf93cfa"
    ],
    "pharm_class_cs": [
      "Sulfonylurea Compounds [CS]"
    ],
    "pharm_class_epc": [
      "Sulfonylurea [EPC]"
    ],
    "manufacturer_name": [
      "Lifsa Drugs LLC"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:72336-641_8f56950f-d08d-44d4-9c7c-9830e9bfadb8"